Syntara Limited (UUD) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pxs-4728 (A) | Rem Sleep Behavior Disorder | Phase II | Active Not Recruiting | Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder | Jun 06, 2023 | ― |
| Pxs-5505 | Myelofibrosis | phase1AndPhase2 | Completed | Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis | Dec 08, 2020 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pxs-4728 (A) | Phase II | Rem Sleep Behavior Disorder | Active Not Recruiting | Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder | Jun 06, 2023 | ― |
| Pxs-5505 | phase1AndPhase2 | Myelofibrosis | Completed | Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis | Dec 08, 2020 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Syntara Limited (CH:UUD) have in its pipeline
Syntara Limited CH:UUD is currently developing the following drugs: Pxs-4728 (A), Pxs-5505. These drug candidates are in various stages of clinical development as the company works toward FDA approval.